Study to Evaluate the Safety and Effectiveness of ELEVIDYS in Participants With Duchenne Muscular Dystrophy Treated in a Post-Marketing Setting
Clinical trial NCT07542314 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07542314
- Sponsor
- Sarepta Therapeutics, Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-31
- Primary completion
- 2027-03-31
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.